Impact of Genetic Polymorphisms on Opioid Misuse: A Scoping Review

References

• Rosenblum A , MarschLA , JosephH , PortenoyRK. Opioids and the treatment of chronic pain: controversies, current status, and future directions. Exp. Clin. Psychopharmacol.16(5), 405–416 (2008).
   PubMed Web of Science ®Google Scholar
• American Society of Addiction Medicine . Opioid Addiction 2016 Facts & Figures. American Society of Addiction Medicine, Rockville, MD, USA (2017).
   Google Scholar
• Division of Unintentional Injury Prevention . Prescribing Data, Opioid Overdose. Centers for Disease Control and Prevention, Atlanta, GA, USA (2017).
   Google Scholar
• Chen LH , HedegaardH , WarnerM. Drug-poisoning Deaths Involving Opioid Analgesics: United States, 1999–2011. NCHS Data Brief (166), 1–8 (2014).
   PubMedGoogle Scholar
• Seth P , SchollL , RuddRA , BaconS. Overdose Deaths Involving Opioids, Cocaine, and Psychostimulants – United States, 2015–2016. MMWR Morb. Mortal. Wkly. Rep.67(12), 349–358 (2018).
   PubMed Web of Science ®Google Scholar
• Canadian Institute for Health Information (CIHI) . Opioid-Related Harms in Canada. CIHI, Ottawa, ON, Canada (2017).
   Google Scholar
• Fischer B , ArgentoE. Prescription opioid related misuse, harms, diversion and interventions in Canada: a review. Pain physician15(3 Suppl.), ES191–ES203 (2012).
   PubMed Web of Science ®Google Scholar
• Fischer B , MurphyY. Policy measures for prescription opioids and harms: enough to protect public health? A comment on Yanovitzky (2016) and Piper et al. (2016). J. Stud. Alcohol Drugs77(4), 566–567 (2016).
   PubMed Web of Science ®Google Scholar
• Fischer B , VojtilaL , RehmJ. The ‘fentanyl epidemic’ in Canada – some cautionary observations focusing on opioid-related mortality. Prev. Med.107, 109–113 (2018).
   PubMed Web of Science ®Google Scholar
• Ballantyne JC , MurinovaN , KrashinDL. Opioid guidelines are a necessary response to the opioid crisis. Clin. Pharmacol. Ther. 103(6), 946–949 (2018).
   PubMed Web of Science ®Google Scholar
• Kahan MM . The opioid crisis in North America. Canadian Family Physician Medecin de Famille Canadien57(5), 536; author reply 537–539 (2011).
   PubMed Web of Science ®Google Scholar
• Ryan SA . Calculating the real costs of the opioid crisis. Pediatrics141(4), pii:e20174129 (2018).
   Web of Science ®Google Scholar
• Vowles KE , McEnteeML , JulnesPS , FroheT , NeyJP , vander Goes DN. Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis. Pain156(4), 569–576 (2015).
   PubMed Web of Science ®Google Scholar
• Wu PE , JuurlinkDN. Unused prescription drugs should not be treated like leftovers. CMAJ186(11), 815–816 (2014).
   PubMed Web of Science ®Google Scholar
• Martin BC , FanMY , EdlundMJ , DevriesA , BradenJB , SullivanMD. Long-term chronic opioid therapy discontinuation rates from the TROUP study. J. Gen. Intern. Med.26(12), 1450–1457 (2011).
   PubMed Web of Science ®Google Scholar
• National Institute on Drug Abuse (NIDA) . Drug Facts: Fentanyl. NIDA, Rockville, MD, USA (2016).
   Google Scholar
• Meibohm B , DerendorfH. Basic concepts of pharmacokinetic/pharmacodynamic (PK/PD) modelling. Int. J. Clin. Pharmacol. Ther.35(10), 401–413 (1997).
   PubMed Web of Science ®Google Scholar
• Smith HS . Variations in opioid responsiveness. Pain Physician11(2), 237–248 (2008).
   PubMed Web of Science ®Google Scholar
• Laugsand EA , FladvadT , SkorpenFet al. Clinical and genetic factors associated with nausea and vomiting in cancer patients receiving opioids. Eur. J. Cancer47(11), 1682–1691 (2011).
   PubMed Web of Science ®Google Scholar
• Laugsand EA , SkorpenF , KaasaSet al. Genetic and non-genetic factors associated with constipation in cancer patients receiving opioids. Clin. Transl. Gastroenterol.6, e90 (2015).
   PubMed Web of Science ®Google Scholar
• Vuilleumier PH , StamerUM , LandauR. Pharmacogenomic considerations in opioid analgesia. Pharmgenomics Pers. Med.5, 73–87 (2012).
   PubMedGoogle Scholar
• Roden DM , AltmanRB , BenowitzNLet al. Pharmacogenomics: challenges and opportunities. Ann. Intern. Med.145(10), 749–757 (2006).
   PubMed Web of Science ®Google Scholar
• Ren ZY , XuXQ , BaoYPet al. The impact of genetic variation on sensitivity to opioid analgesics in patients with postoperative pain: a systematic review and meta-analysis. Pain Physician18(2), 131–152 (2015).
   PubMed Web of Science ®Google Scholar
• Al-Hasani R , BruchasMR. Molecular mechanisms of opioid receptor-dependent signaling and behavior. Anesthesiology115(6), 1363–1381 (2011).
   PubMed Web of Science ®Google Scholar
• Park HJ , ShinnHK , RyuSH , LeeHS , ParkCS , KangJH. Genetic polymorphisms in the ABCB1 gene and the effects of fentanyl in Koreans. Clin. Pharmacol. Ther.81(4), 539–546 (2007).
   PubMed Web of Science ®Google Scholar
• Arksey H , O’MalleyL. Scoping studies: towards a methodological framework. Int. J. Soc. Res. Methodol.8(1), 19–32 (2005).
   Google Scholar
• Nishizawa D , FukudaK , KasaiSet al. Association between KCNJ6 (GIRK2) gene polymorphism rs2835859 and post-operative analgesia, pain sensitivity, and nicotine dependence. J. Pharmacol. Sci.126(3), 253–263 (2014).
   PubMed Web of Science ®Google Scholar
• Carlquist JF , MoodyDE , KnightSet al. A possible mechanistic link between the CYP2C19 genotype, the methadone metabolite ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidene (EDDP), and methadone-induced corrected QT interval prolongation in a pilot study. Mol. Diagn. Ther.19(2), 131–138 (2015).
   PubMed Web of Science ®Google Scholar
• Chidambaran V , VenkatasubramanianR , ZhangXet al. ABCC3 genetic variants are associated with postoperative morphine-induced respiratory depression and morphine pharmacokinetics in children. Pharmacogenomics J.17(2), 162–169 (2017).
   PubMed Web of Science ®Google Scholar
• Bunten H , LiangWJ , PounderDJ , SeneviratneC , OsseltonD. OPRM1 and CYP2B6 gene variants as risk factors in methadone-related deaths. Clin. Pharmacol. Ther.88(3), 383–389 (2010).
   PubMed Web of Science ®Google Scholar
• Sorokina VV . Genetic markers in forensic medical examination of acute and chronic opioid intoxication. Sudebno-Meditsinskaia Ekspertiza53(1), 19–21 (2010).
   PubMedGoogle Scholar
• Balyan R , ZhangX , ChidambaranVet al. OCT1 genetic variants are associated with postoperative morphine-related adverse effects in children. Pharmacogenomics18(7), 621–629 (2017).
   PubMed Web of Science ®Google Scholar
• Biesiada J , ChidambaranV , WagnerMet al. Genetic risk signatures of opioid-induced respiratory depression following pediatric tonsillectomy. Pharmacogenomics15(14), 1749–1762 (2014).
   PubMed Web of Science ®Google Scholar
• Chidambaran V , MaviJ , EsslingerHet al. Association of OPRM1 A118G variant with risk of morphine-induced respiratory depression following spine fusion in adolescents. Pharmacogenomics J.15(3), 255–262 (2015).
   PubMed Web of Science ®Google Scholar
• Chidambaran V , PilipenkoV , SpruanceKet al. Fatty acid amide hydrolase-morphine interaction influences ventilatory response to hypercapnia and postoperative opioid outcomes in children. Pharmacogenomics18(2), 143–156 (2017).
   PubMed Web of Science ®Google Scholar
• Currow DC , QuinnS , EkstromMet al. Can variability in the effect of opioids on refractory breathlessness be explained by genetic factors? BMJ Open 5(5), e006818 (2015).
   PubMed Web of Science ®Google Scholar
• Ballon N , LeroyS , RoyCet al. (AAT)n repeat in the cannabinoid receptor gene (CNR1): association with cocaine addiction in an African-Caribbean population. Pharmacogenomics J.6(2), 126–130 (2006).
   PubMed Web of Science ®Google Scholar
• Clarke TK , CristRC , KampmanKMet al. Low frequency genetic variants in the mu-opioid receptor (OPRM1) affect risk for addiction to heroin and cocaine. Neurosci. Lett.542, 71–75 (2013).
   PubMed Web of Science ®Google Scholar
• Clarke TK , KrauseK , LiT , SchumannG. An association of prodynorphin polymorphisms and opioid dependence in females in a Chinese population. Addict. Biol.14(3), 366–370 (2009).
   PubMed Web of Science ®Google Scholar
• Clarke TK , WeissAR , FerarroTNet al. The dopamine receptor D2 (DRD2) SNP rs1076560 is associated with opioid addiction. Ann. Hum. Genet.78(1), 33–39 (2014).
   PubMed Web of Science ®Google Scholar
• Doehring A , HentigN , GraffJet al. Genetic variants altering dopamine D2 receptor expression or function modulate the risk of opiate addiction and the dosage requirements of methadone substitution. Pharmacogenet. Genomics19(6), 407–414 (2009).
   PubMed Web of Science ®Google Scholar
• Gelernter J , KranzlerHR , ShervaRet al. Genome-wide association study of opioid dependence: multiple associations mapped to calcium and potassium pathways. Biolo. Psychiatry76(1), 66–74 (2014).
   PubMed Web of Science ®Google Scholar
• Hancock DB , LevyJL , GaddisNCet al. Replication of ZNF804A gene variant associations with risk of heroin addiction. Genes Brain Behav.14(8), 635–640 (2015).
   PubMed Web of Science ®Google Scholar
• Jacobs MM , OkvistA , HorvathMet al. Dopamine receptor D1 and postsynaptic density gene variants associate with opiate abuse and striatal expression levels. Mol. Psychiatry18(11), 1205–1210 (2013).
   PubMed Web of Science ®Google Scholar
• Kumar D , DebI , ChakrabortyJ , MukhopadhyayS , DasS. A polymorphism of the CREB binding protein (CREBBP) gene is a risk factor for addiction. Brain Res.1406, 59–64 (2011).
   PubMed Web of Science ®Google Scholar
• Levran O , RandesiM , PelesEet al. African-specific variability in the acetylcholine muscarinic receptor M4: association with cocaine and heroin addiction. Pharmacogenomics17(9), 995–1003 (2016).
   PubMed Web of Science ®Google Scholar
• Liu Z , GuoX , JiangY , ZhangH. NCK2 is significantly associated with opiates addiction in African-origin men. ScientificWorldJournal 2013, 748979 (2013).
   PubMedGoogle Scholar
• Nagaya D , ZahariZ , SaleemM , YahayaBH , TanSC , YusoffNM. An analysis of genetic association in opioid dependence susceptibility. J. Clin. Pharm. Ther.43(1), 80–86 (2018).
   PubMed Web of Science ®Google Scholar
• Nelson EC , AgrawalA , HeathACet al. Evidence of CNIH3 involvement in opioid dependence. Mol. Psychiatry21(5), 608–614 (2016).
   PubMed Web of Science ®Google Scholar
• Pal A , ChakrabortyJ , DasS. Association of CREB1 gene polymorphism with drug seeking behaviour in eastern Indian addicts. Neurosci. Lett.570, 53–57 (2014).
   PubMed Web of Science ®Google Scholar
• Wang TY , LeeSY , ChungYLet al. TPH1 and 5-HTTLPR genes specifically interact in opiate dependence but not in alcohol dependence. Eur. Addict. Res.22(4), 201–209 (2016).
   PubMed Web of Science ®Google Scholar
• Xie X , XuL , LiuHet al. Positive association between -1021TT genotype of dopamine beta hydroxylase gene and progressive behavior of injection heroin users. Neurosci. Lett.541, 258–262 (2013).
   PubMed Web of Science ®Google Scholar
• Yuferov V , JiF , NielsenDAet al. A functional haplotype implicated in vulnerability to develop cocaine dependence is associated with reduced PDYN expression in human brain. Neuropsychopharmacology34(5), 1185–1197 (2009).
   PubMed Web of Science ®Google Scholar
• Henker RA , LewisA , DaiFet al. The associations between OPRM 1 and COMT genotypes and postoperative pain, opioid use, and opioid-induced sedation. Biol. Res. Nurs.15(3), 309–317 (2013).
   PubMed Web of Science ®Google Scholar
• Randesi M , vanden Brink W , LevranOet al. Variants of opioid system genes are associated with non-dependent opioid use and heroin dependence. Drug Alcohol. Depend.168, 164–169 (2016).
   PubMed Web of Science ®Google Scholar
• Chen CH , WangSC , TsouHHet al. Genetic polymorphisms in CYP3A4 are associated with withdrawal symptoms and adverse reactions in methadone maintenance patients. Pharmacogenomics12(10), 1397–1406 (2011).
   PubMed Web of Science ®Google Scholar
• Levran O , O’HaraK , PelesEet al. ABCB1 (MDR1) genetic variants are associated with methadone doses required for effective treatment of heroin dependence. Hum. Mol. Genet.17(14), 2219–2227 (2008).
   PubMed Web of Science ®Google Scholar
• Muldoon PP , JacksonKJ , PerezEet al. The alpha3beta4* nicotinic ACh receptor subtype mediates physical dependence to morphine: mouse and human studies. Br. J. Pharmacol.171(16), 3845–3857 (2014).
   PubMed Web of Science ®Google Scholar
• Tian JN , HoIK , TsouHHet al. UGT2B7 genetic polymorphisms are associated with the withdrawal symptoms in methadone maintenance patients. Pharmacogenomics13(8), 879–888 (2012).
   PubMed Web of Science ®Google Scholar
• Wachman EM , HayesMJ , ShervaRet al. Variations in opioid receptor genes in neonatal abstinence syndrome. Drug Alcohol. Depend.155, 253–259 (2015).
   PubMed Web of Science ®Google Scholar
• Smith HS . Opioid metabolism. Mayo Clin. Proc.84(7), 613–624 (2009).
   PubMed Web of Science ®Google Scholar
• Pasternak GW . Molecular biology of opioid analgesia. J. Pain Symptom Manag.29(5 Suppl.), S2–S9 (2005).
   PubMed Web of Science ®Google Scholar
• Pattinson KT . Opioids and the control of respiration. Br. J. Anaesth.100(6), 747–758 (2008).
   PubMed Web of Science ®Google Scholar
• Fine PG , PortenoyRK. A Clinical Guide to Opioid Analgesia, 2nd Edition. New York, NY, USA (2007).
   Google Scholar
• Domschke K , StevensS , BeckBet al. Blushing propensity in social anxiety disorder: influence of serotonin transporter gene variation. J. Neural. Transm.116(6), 663–666 (2009).
   PubMed Web of Science ®Google Scholar
• Contet C , KiefferBL , BefortK. Mu opioid receptor: a gateway to drug addiction. Curr. Opin. Neurobiol.14(3), 370–378 (2004).
   PubMed Web of Science ®Google Scholar
• Kalivas PW . The glutamate homeostasis hypothesis of addiction. Nat. Rev. Neurosci.10(8), 561–572 (2009).
   PubMed Web of Science ®Google Scholar